Mark Laftavi profile picture
Accepting New Patients
315-464-7329

Mark Laftavi, MD, FACS, FICS

CURRENT APPOINTMENTS

Professor of Surgery
Interim Chief of Transplant Services
Interim Chief of Transplant Clinic

SPECIALTIES

Transplant

LANGUAGES

English
Farsi
Arabic
French

PATIENT TYPE

Adults and Children

CLINICAL TRIALS

A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant (ReGIFT)
Read more
Astagraf XL® to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation (ASTOUND)
Read more
A Prospective Observational Trial to Evaluate the Correlation of T-SPOT Response to CMV Infection and t cell-mediated Acute Graft Rejection
Read more

DISEASES & CONDITIONS TREATED

Immunocompromised Patient and Surgery
Pancreatic Disease
Pediatric Kidney Disease and Transplant
Renal Transplant

TREATMENTS / SERVICES

Pancreas and Kidney Transplantation

CLINICAL LOCATIONS

Upstate University Hospital
750 East Adams Street
Syracuse, NY 13210
315-464-5413

CLINICAL SECTION AFFILIATIONS

Surgery
Transplant Services

CURRENT HOSPITAL PRIVILEGES

Upstate University Hospital